Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Access of Etravirine (TMC125) in Treatment-Experienced HIV-1
NCT00354627Phase 3Completed
- Sponsor
- Tibotec
- Start
- Jan 2006
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of etravirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Jan 2006; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00354627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354627.